Ttk Healthcare Limited (TTKHLTCARE)
ISIN: INE910C01018 Industry: Drug Manufacturers—General Sector: Healthcare Website
814
26.85(3.41%)

TTK Healthcare Limited engages in the pharmaceutical, consumer product, medical device, protective device, and food businesses in India and internationally. The company's Pharmaceuticals segment deals in herbal and allopathic formulations for human and veterinary uses. It offers pharmaceutical products for various therapeutic segments, such as gynecology, infertility, respiratory, orthopedics, cardiology, and general health, as well as provides food supplements. Its Consumer Products segment is involved in marketing and distribution of Woodwards's Gripe Water, EVA range of cosmetics, Good Home range of scrubbers, air fresheners, etc. The company's Medical Devices segment manufactures and distributes artificial heart valves; and develops orthopedic implants and instruments. Its Protective Devices segment manufactures and markets male contraceptives and other allied products. The company's Foods segment manufactures and markets food products, including potato and cereal based pellets. Its Others segment prints and publishes maps and atlases. The company was incorporated in 1958 and is headquartered in Chennai, India. TTK Healthcare Limited is a subsidiary of T T Krishnamachari & Co., Ltd.

Pricing Updates

TODAY'S HIGH

829

TODAY'S LOW

790

52 WEEK HIGH

934

52 WEEK LOW

622.35

Major Holders

% of Shares Held by
All Insider

76.65%

% of Shares Held by
Institutions

7.62%

% of Float Held by
Institutions

32.62%

Number of Institutions
Holding Shares

4

Company Overview

MARKET CAP

1150.20 Cr.

ETERPRISE VALUE

860.30 Cr.

NO. OF SHARES

1.41 Cr.

BOOK VALUE

233.42

DIV. YIELD

10%

DEBT

22.21 Cr.

GROSS PROFIT

317.74 Cr.

CASH

273.50 Cr.

REVENUE

599.23 Cr.

REVENUE/SHARE

424.053

OHLC Chart 1y 2y 5y 10y

Price Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Volumes Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Cashflows

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Investments-40.50 Cr.-93.60 Cr.-10.06 Cr.6.48 Cr.
Change To Liabilities13 Cr.11.19 Cr.15.49 Cr.-13.61 Cr.
Total cashflows from Investing Activities-30.54 Cr.-77.23 Cr.-13.29 Cr.9.65 Cr.
Net Borrowings3.30 Cr.-10.69 Cr.1.62 Cr.-18.83 Cr.
Total Cash from Financing Activities-9.13 Cr.-17.15 Cr.-10.16 Cr.-30.72 Cr.
Other Liabilities8.85 Cr.12.76 Cr.1.39 Cr.22.16 Cr.
Total Assets0000
Net Income41.58 Cr.46.44 Cr.12.31 Cr.24.37 Cr.
Change in Cash5.30 Cr.2.02 Cr.-3.62 Cr.-3.76 Cr.
Effect of Exchange Rate0000
Total Cash from Operating Activities44.99 Cr.96.42 Cr.19.83 Cr.17.30 Cr.
Depreciation13.18 Cr.13.62 Cr.14.27 Cr.14.32 Cr.
Other Cashflows from Investing Activities13.87 Cr.18.03 Cr.8.30 Cr.7.47 Cr.
Dividends Paid-8.47 Cr.-4.23 Cr.-7.06 Cr.-7.06 Cr.
Change to Inventory-16.12 Cr.1.34 Cr.-16.33 Cr.-2.41 Cr.
Change to Account Receivables-9.60 Cr.15.87 Cr.3.47 Cr.-24.90 Cr.
Other Cashflows from Financing Activities-3.96 Cr.-2.22 Cr.-4.72 Cr.-4.83 Cr.
Change to Net Income-5.92 Cr.-4.91 Cr.-10.88 Cr.-2.96 Cr.
Capital Expenditures-6.49 Cr.-1.73 Cr.-12.23 Cr.-4.32 Cr.

Financials

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Research DevelopmentNoneNoneNoneNone
Effect of Accounting ChargesNoneNoneNoneNone
Income Before Tax24.83 Cr.37.05 Cr.19.42 Cr.39.25 Cr.
Minority InterestNoneNoneNoneNone
Net Income9.25 Cr.21.31 Cr.14.51 Cr.35.86 Cr.
Selling General Administrative102.84 Cr.241.75 Cr.235.01 Cr.130.80 Cr.
Gross Profit317.74 Cr.372.46 Cr.374.19 Cr.365.29 Cr.
Ebit9.25 Cr.21.31 Cr.14.51 Cr.35.86 Cr.
Operating Income9.25 Cr.21.31 Cr.14.51 Cr.35.86 Cr.
Other Operating Expenses193.06 Cr.95.40 Cr.109.78 Cr.184.05 Cr.
Interest Expense-3.23 Cr.-2.10 Cr.-3.14 Cr.-3.25 Cr.
Extraordinary ItemsNoneNoneNoneNone
Non RecurringNoneNoneNoneNone
Other ItemsNoneNoneNoneNone
Income Tax Expense6.32 Cr.-9.38 Cr.7.10 Cr.14.88 Cr.
Total Revenue599.23 Cr.636.52 Cr.645.76 Cr.627.88 Cr.
Total Operating Expenses589.98 Cr.615.21 Cr.631.25 Cr.592.01 Cr.
Cost of Revenue281.49 Cr.264.06 Cr.271.56 Cr.262.59 Cr.
Total Other Income Expense Net15.58 Cr.15.73 Cr.4.91 Cr.3.38 Cr.
Discontinued Operations23.07 Cr.23.07 Cr.23.07 Cr.23.07 Cr.
Net Income from Continuous Ops.18.51 Cr.46.44 Cr.12.31 Cr.24.37 Cr.
Net Income Applicable to Common Shares41.58 Cr.46.44 Cr.12.31 Cr.24.37 Cr.

Balance Sheet

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Intangible Assets8.63 Lakhs15.35 Lakhs23.70 Lakhs33.56 Lakhs
Capital Surplus09.82 Cr.9.82 Cr.9.82 Cr.
Total Liabilities228.91 Cr.199.62 Cr.182.21 Cr.164.38 Cr.
Stock Holder Equity329.63 Cr.294.64 Cr.248.99 Cr.251.42 Cr.
Minority Interest0000
Other Liabilities91.88 Cr.28.86 Cr.27 Cr.26.52 Cr.
Total Assets558.54 Cr.494.27 Cr.431.20 Cr.415.81 Cr.
Common Stock14.13 Cr.14.13 Cr.14.13 Cr.14.13 Cr.
Retained Earnings0246.19 Cr.204.93 Cr.203.07 Cr.
Other Liabilities7.04 Cr.9.70 Cr.9.44 Cr.6.97 Cr.
Good Will0000
Treasury Stock315.50 Cr.24.50 Cr.20.10 Cr.24.39 Cr.
Other Assets14.44 Cr.20.44 Cr.27.33 Cr.31.94 Cr.
Cash273.50 Cr.9.55 Cr.7.52 Cr.11.15 Cr.
Current Liabilities220.53 Cr.188.76 Cr.171.50 Cr.157.07 Cr.
Long Term Asset Charges7.30 Cr.6.45 Cr.4.16 Cr.4.87 Cr.
Short Long Term Debt0000
Other Stockholder Equity315.50 Cr.24.50 Cr.20.10 Cr.24.39 Cr.
Property Plant Equipment80.37 Cr.85.63 Cr.97.18 Cr.98.76 Cr.
Total Cur. Assets448.51 Cr.374.87 Cr.297.70 Cr.271.71 Cr.
Long Term Investments15.13 Cr.13.16 Cr.8.75 Cr.13.04 Cr.
Net Tangible Assets329.54 Cr.294.49 Cr.248.75 Cr.251.09 Cr.
Short Term Investments0217.44 Cr.122.86 Cr.112.53 Cr.
Net Receivables53.58 Cr.63.98 Cr.82.15 Cr.83.17 Cr.
Long Term Debt0000
Inventory78.92 Cr.70.30 Cr.71.64 Cr.55.30 Cr.
Accounts Payable103.45 Cr.97.60 Cr.86.50 Cr.72.71 Cr.

New Offers


Upstox offer
Upstox

Open a demat account through us and get the account opening charges waived off

open paperless account